Catching up with the CRISPR craze: applications of genome editing in Medicine, Ag and beyond
January 26, 2021
Dr. Rodolphe Barrangou
The advent of CRISPR-based technologies has revolutionized our ability to manipulate the genetic content of organisms across the tree of life and democratized genome editing across the globe. Actually, genome editing technologies have been broadly deployed in academia and industry in the past 8 years, to manipulate the genomes of organisms relevant to medicine, biotechnology and agriculture. I will look back on the historical milestones that have paved the way for the CRISPR era, discuss the business potential of this disruptive technology, and account for regulatory frameworks, public engagement, investment opportunities and competitive landscape implications.
Bio
Rodolphe Barrangou Ph.D. is the T. R. Klaenhammer Distinguished Professor in Probiotics Research at North Carolina State University. Barrangou is focusing on the characterization of CRISPR Cas systems, and their applications in bacteria. For his CRISPR work, Rodolphe received several awards, including the Canada Gairdner International Award. Dr. Barrangou is also a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo, Ancilia Biosciences and CRISPR biotechnologies, and the Editor in Chief of the CRISPR Journal.
